<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0238615.ref014">
 <label>14</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fukao</surname>
   <given-names>K</given-names>
  </name>, 
  <name>
   <surname>Ando</surname>
   <given-names>Y</given-names>
  </name>, 
  <name>
   <surname>Noshi</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Kitano</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Noda</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Kawai</surname>
   <given-names>M</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models</article-title>. 
  <source>PLoS One</source>. 
  <year>2019</year>;
  <volume>14</volume>(
  <issue>5</issue>):
  <fpage>e0217307</fpage> Epub 2019/05/21. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0217307</pub-id>
  <?supplied-pmid 31107922?>
  <pub-id pub-id-type="pmid">31107922</pub-id>
 </mixed-citation>
</ref>
